EFTA01108077.pdf

5151 CORPORATE WAY JUPITER, FL. 33458-3101 MHDIDAL 1...AMOPATOrite Et (866)720-8386 Client: BRUCE MOSKOWITZ, M.D. 2622 Patient EPSTEIN, JEFFREY 1411 N. PLAGLER DR. Room,/ DOB. 01/20/1953 Age:63 Sex:M SUITE 7100 Phone: Fasting: N WEST PALM BEACH, FL 33401 ID#: 262219530120MJE Phys: MOSKOWITZ, BRUCE Route#: 0 Page:1 Acc# 001081881 Coll. Date: 03/28/16 Recv. Date: 03/28/16 Print Date: 03/30/16 Chart# 19530120MIE Coll. Time: 00:00 AM Recv. Time:16:54:03 Print Time: 07:40 First reported on: 03/28/1 6 Final report date: 03/29/16 Test Name Results Normal Range I Units Report Status: FINAL COMMENTS: COMPLETE BLOOD COUNT WHITE BLOOD CELL 3.1 L 3.9 - 11.1 K/ul Slide made RED BLOOD CELL 5.18 4.2 - 6.0 hil/u1 HEMOGLOBIN 14.7 3.3.2 - 18.0 FAH HEMATOCRIT 44.9 38.5 - 54.0 MCV 87 80.0 - 100.0 MCH 28.4 26.0 - 34.0 PS MCHC 32.8 31.0 - 37.0 gMl RDW 13.8 11.0 - 15.5 PLATELET COUNT 259 140 - 400 Wul MPV 9.3 7.5 - 11.6 11 DIFFERENTIAL GR% 37.0 L 38 - 75 LY% 41.8 15 - 49 MO% 11.1 2.0 - 13.0 FO% 8.6 0 - HA% 1.5 0 - 2 GR# 1.2 L 1.6 - 8.4 Kful LY# 1.3 1.0 - 3.6 Khl MO# 0.3 0.0 - 0.9 KM1 EON 0.3 0.0 - 0.6 1C/u1 BA# 0.0 0.0 - 0.2 Vol Smear review agrees with automated differential. HEMATOLOGY TESTS Sedimentation Rat!:, 25 H 0 - 20 mm/hr GENERAL CHEMISTRY GLUCOSE 107 H 65 - 100 mgidl BUN 26 H 6 - 20 mg/dl CREATININE, SERUM 1.0 0.5 - 1.2 mg/dl URIC ACID 6.3 3.4 - 7.0 mg/dl SODIUM 139 133 - 145 mmoLL POTASSIUM 4.5 3.3 - 5.1 Inmuld CHLORIDE 101 96 - 108 mmoht CO2 22 22 - 32 mmol;L CALCIUM 9.8 8.5 - 10.5 tug/di (Continued onNat Page) EFTA01108077 gorgilltbICAL Client BRUCE MOSKOWITZ,M.D. 1411 N.FLAGLER DR. LACIORATORIE 2622 : Patient: Room# 5151(238PCHIATEHLAY JUPITER.FL33458-310I (866)7204386 EPSTEKJEFFREY DOB. 01/20/1953 Agc:63 Sex:M SUITE 7100 Phone: Fasting: N WESTPALM BEACH,FL33401 11)#: 262219530120h4IE Phys: MOSKOWITZ,BRUCE Routo#: 0 Pagc:2 Aceti 001081881 Coll. Date: 03/28/16 Recv. Date: 03/28/16 Print Date: 03/30/16 Chart# 19530120MJE Coll. Time: 00:00 AM Recv. Time:16:54:03 Print Time: 07:40 First reported on: 03/28/16 Final report date: 03/29/16 ' Test Name Results Normal Range I Units GENERAL CHEMISTRY (Continued) TOTAL PROTEIN 6.9 6.4 - 8.3 ALBUMIN 4.3 3.2 - 4.8 Wdl GLOBULIN 2 .6 2.1 - 3.6 g/dl BILTRUBIN,TOTAL 0.6 0.0 • 1.0 rn/dl ALKALINE PHOSPHATASE 57 35 - 129 ALT 25 <42 U/L AST 19 <39 U/L Allaunin/Globulin Ratio 1.7 0.8 - 2.0 BUN/CREAT RATIO 26.0 H 7.3 - 21.7 GFR,estimated 80 mAtmin If African-American result is:>60 Calculation of estimated GFR is based on the MDRD Study prediction aquatic'', ****Five Stages of Chronic Kidney Disease**** *Stage* *OFR Level* *Description* Stage 1 90 ml/min or more Healthy Kidneys or Kidney damage with normal or high GFR Stage 2 60 to 89 ml/min Kidney damage and mild decrers in OFR Stage 3 30 to 59 ml/min Moderate decrease in OFR Stage 4 15 to 29 ml/min Severe decrease in OFR Stage 5 < 15 ml/min Kidney failure, or on dialysis DIABETES EVALUATION HEMOGLOBIN A1C 5.6 < 5.7 95 ***Diagnosis*** ***HhAlc Level*** Normal < 5.7 * Prediabeteu 5.7 - 6.4 t Diabetes or > 6.5 t Having prediabetes is a Risk Factor for getting type 2 diabetes. Within the prediabetes range(5.7-6.4), the higher the HbA1c,the greater the risk of diabetes. HbA1c target for diabetics depend on their history and health. IRON/ANEMIA EVALUATION : \MIN HI"' 405 243 - 894 Peng CORONARY RISK TRIGLYCERIDES 712 H <150 mg/dl CHOLESTEROL,TOTAL 206 H <200 tngidi (Continued on Next Page) EFTA01108078  frakAcres IEDICAL Client: BRUCE MOSKOWITZ., M.D. LASCIFIATORICEI 2622 Patient: 5151 CORPORATE WAY JUPITER, fl. 33458-3101 (4661120-8386 EPSTEIN, JEFFREY 1411 N. FLAGLER DR. Rowe DOB. 01/20/1953 Agc:63 Scx:M SUITE 7100 Phone: Fasting: N WEST PALM BEACH, FL 33401 ID#: 262219530120MJE Phys: MOSKOWITZ, BRUCE Route#: 0 Page3 Acdt 001081881 Coll. Date: 03/28/16 Rees. Date: 03/28/16 Print Date: 03130/16 Chant/ 19530120MJE Coll. Time: 00:00 AM Recv. Time:16:54:03 Print Time: 07:40 First reported on: 03/28/16 Final report date: 03/29/16 Test Name Results Normal Range I Units CORONARY RISK (Continued) IIDL CHOLESTEROL 23 L >40 mg/d1 CHOL/HDL RATIO 9.0 H <5.0 The higher the Ratio,the higher CND risk. CRP, Cardio 1. 7 <3.0 mg/L. **Risk of Cardiovasular Disease** Low Risk CRP < 1.0 mg/L Medium Risk CRP 1.0 - 3.0 mg/L High Risk CRP > 3.0 mg/L HOMOCYSTEINE 16.2 H 4.5 - 15.0 ummUL Ideal level <8.0 umo1/1, THYROID TESTING T-Uptake 1.03 0.8 - 1.3 TBI T4,FREE 1.10 0.9 - 1.7 ng/dl TSH 1.800 0.27 - 4.2 ulUhnl TUMOR MARKERS PSA, TOTAL 0.595 0.0 - 4.0 nerM ENDOCRINE EVALUATION PROLACTIN 4.2 4.1 - 18.4 TESTOSTERONE, TOTAL 105 L 280 - 1100 Parathyroid Hormone, Intact 63.1 15 - 65 OTHER TESTS VITAMIN D,25-HYDROXY Vitamin D,25-011,Total 40 >30 nghral Rotes: Therapy is based on the measurement of Total Vitamin D (25-OH). Most experts agree that Vitamin D deficiency should be = or < 20 ng/ml. Vitamin D insufficiency is recognized as 21 - 29 ng/ml. The prefered level for Vitamin D (25-OH)is recommended to be = or >30 nghoil (Continued on NextPage) EFTA01108079 140Appeisa Client: BRUCE MOSKOWITZ, M.D. 2622 Patient: 5151 CORPORATE WAY JUPITER, FL 33458-3101 (866)7204386 EPSTEIN, JEFFREY 1411 N. FLAGLER DR. Room# DOB. 01/20/1953 Age:63 Sex:M SUITE 7100 Phone: Fasting: N WEST PALM BEACH, FL 33401 ID#: 262219530120MJE Phys: MOSKOWITZ, BRUCE Route#: 0 Page:4 Acc# 001081881 Coil. Date: 03/28/16 Recv. Date: 03/28/16 Print Date: 03/30/16 Chart# 19530120MJE Coll. Time: 00:00 AM Recv. Time:16:54:03 Print Time: 07:40 First reported on: 03/28/16 Final report date: 03/29/16 Test Name Results I Normal Range Units SEROLOGY CRP, inflammation 1.7 B.0 . END OF REPORT EFTA01108080